Reaction

Hyperoxaluria reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 172 reports · 5 co-occurring drugs

As of the last recalculation, Hyperoxaluria appears in 172 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is DAPTOMYCIN (PRR 154.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Daptomycin11154.1154.3
Micafungin Sodium8119.7119.8
Orlistat1788.088.1
Cefepime980.180.2
Cefepime Hydrochloride971.371.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.